- Fund name: Life Sciences Partners VI (LSP 6)
- Amount raised: $600 million
- Target size: $450 million
- Hard-cap: $600 million
- Stage of fundraising: Final close
- Final close date: March 2020
- Predecessor fund: Life Sciences Partners V (LSP 5) ($280 million)
Life Science Partners has closed its latest fund at its $600 million hard-cap. Life Sciences Partners VI (LSP 6) will follow the investment strategy of its predecessor funds investing in 15-18 predominantly European private companies developing new medications or medical technologies.